Roberto Machado is a Respiratory physician. OpenAlex indexes 402 publications with 15,394 citations (h-index 57); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1801 N. Senate Blvd
Suite 2000
Indianapolis, IN 46202
Telephone
317-962-9700Provider last certified this registry record 8 Oct 2025.
Clinical trials
- High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus
Sponsor: Hospital Universitário Professor Edgard Santos
- Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension
Sponsor: University of Illinois at Chicago
- Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis
Sponsor: Paulo Roberto Lima Machado
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Actelion Pharmaceuticals US, Inc.Program year20251 payment
- United Therapeutics CorporationProgram year20241 payment
- Sandoz Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
5 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- IU Training Program in Molecular Physiology and Clinical Mechanisms of Lung Disease
Indiana University Indianapolis
FY2026$438,887T32HL091816 - NAD-dependent Signaling and Pulmonary Vascular Remodeling in PAH
Indiana University Indianapolis
FY2025$518,576R01HL158108 - Vascular Targeting Genomic & Genetic Strategies for Acute Chest Syndrome
Indiana University Indianapolis
FY2025$344,205R01HL111656
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019
Critical Care Explorations
2020 - Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor
American Journal of Respiratory and Critical Care Medicine
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”